• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用严重程度作为预测青少年阿片类药物使用障碍接受药物治疗的指标:对 2019 年 TEDS 的分析。

Substance use severity as a predictor for receiving medication for opioid use disorder among adolescents: An analysis of the 2019 TEDS.

机构信息

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1821 Clifton Road, NE, Atlanta, GA 30329, USA.

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1821 Clifton Road, NE, Atlanta, GA 30329, USA.

出版信息

Drug Alcohol Depend. 2023 May 1;246:109850. doi: 10.1016/j.drugalcdep.2023.109850. Epub 2023 Mar 23.

DOI:10.1016/j.drugalcdep.2023.109850
PMID:36989708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10121859/
Abstract

BACKGROUND

Medication for opioid use disorder (MOUD) is vastly underutilized in adolescents. Existing treatment guidelines for OUD largely focus on adults, providing limited guidance for pediatric populations. Limited information is known about use of MOUD in adolescents based on substance use severity.

METHODS

This secondary data analysis examined how patient-level variables influenced the receipt of MOUD in adolescents aged 12-17 (n = 1866) using the Treatment Episode Data Set (TEDS) 2019 Discharge data set. A crosstabulation and chi-square statistic evaluated the relationship between a proxy for clinical need based on high-risk opioid use (either reporting daily opioid use within the past 30 days and/or history of injection opioid use) for MOUD in states with and without adolescents receiving MOUD (n = 1071). A two-step logistic regression analysis in states with any adolescents receiving MOUD examined the explanatory power of demographic, treatment intake, and substance use characteristics.

RESULTS

Completion of 12th grade, a GED, or beyond, decreased the likelihood of receiving MOUD (odds ratio [OR]= 0.38, p = 0.017), as did being female (OR = 0.47, p = .006). None of the remaining clinical criteria were significantly associated with MOUD, although a history of one or more arrests increased the likelihood of MOUD (OR = 6.98, p = 0.06). Only 13% of individuals who met criteria for clinical need received MOUD.

CONCLUSIONS

Lower education could serve as a proxy for substance use severity. Guidelines and best practices are needed to ensure the proper distribution of MOUD to adolescents based on clinical need.

摘要

背景

阿片类药物使用障碍(MOUD)的药物治疗在青少年中未得到广泛应用。现有的 OUD 治疗指南主要针对成年人,为儿科人群提供的指导有限。根据物质使用的严重程度,青少年使用 MOUD 的信息有限。

方法

本二次数据分析使用 2019 年 TEDS 出院数据集,考察了患者水平变量如何影响 12-17 岁青少年(n=1866)接受 MOUD 的情况。通过交叉表和卡方检验,评估了在有和没有青少年接受 MOUD 的州,基于高风险阿片类药物使用(在过去 30 天内报告每日使用阿片类药物和/或注射阿片类药物使用史)的临床需要代理变量与青少年接受 MOUD 之间的关系(n=1071)。在有任何青少年接受 MOUD 的州,进行了二步逻辑回归分析,以考察人口统计学、治疗摄入和物质使用特征的解释力。

结果

完成 12 年级、GED 或更高学历,降低了接受 MOUD 的可能性(优势比[OR]=0.38,p=0.017),女性(OR=0.47,p=0.006)也是如此。其余的临床标准与 MOUD 均无显著相关性,尽管有一次或多次被捕记录会增加 MOUD 的可能性(OR=6.98,p=0.06)。仅有 13%符合临床需要标准的人接受了 MOUD。

结论

较低的教育程度可能是物质使用严重程度的一个指标。需要制定指南和最佳实践,以确保根据临床需要向青少年适当分配 MOUD。

相似文献

1
Substance use severity as a predictor for receiving medication for opioid use disorder among adolescents: An analysis of the 2019 TEDS.物质使用严重程度作为预测青少年阿片类药物使用障碍接受药物治疗的指标:对 2019 年 TEDS 的分析。
Drug Alcohol Depend. 2023 May 1;246:109850. doi: 10.1016/j.drugalcdep.2023.109850. Epub 2023 Mar 23.
2
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.2019 年美国需要阿片类药物治疗的青少年和成年人中,阿片类药物使用障碍药物治疗的使用情况。
JAMA Netw Open. 2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821.
3
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.青少年和青年中阿片类使用障碍治疗入院的趋势和与年龄相关的差异。
J Subst Abuse Treat. 2022 Jan;132:108584. doi: 10.1016/j.jsat.2021.108584. Epub 2021 Aug 8.
4
Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.美国接受治疗的孕妇药物滥用障碍用药的相关因素
Int J Drug Policy. 2024 Apr;126:104342. doi: 10.1016/j.drugpo.2024.104342. Epub 2024 Mar 13.
5
Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.阿片类物质使用障碍及共病多种物质使用中丁丙诺啡与纳曲酮的疗效比较。
JAMA Netw Open. 2022 May 2;5(5):e2211363. doi: 10.1001/jamanetworkopen.2022.11363.
6
Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.在同时存在物质使用问题的退伍军人中治疗阿片类药物使用障碍:在初级保健、心理健康和疼痛环境中使用丁丙诺啡的提供者的定性研究。
Addict Sci Clin Pract. 2023 May 4;18(1):26. doi: 10.1186/s13722-023-00382-1.
7
The cascade of care for opioid use disorder among youth in British Columbia, 2018.不列颠哥伦比亚省青年阿片类药物使用障碍的照护级联,2018 年。
J Subst Abuse Treat. 2021 Nov;130:108404. doi: 10.1016/j.jsat.2021.108404. Epub 2021 Apr 18.
8
Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.美国监狱中妊娠和产后个体阿片类药物使用障碍治疗药物的可及性。
JAMA Netw Open. 2022 Jan 4;5(1):e2144369. doi: 10.1001/jamanetworkopen.2021.44369.
9
Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.多物质使用障碍与医疗补助受益的阿片类药物使用障碍患者的治疗质量之间的关联。
J Subst Abuse Treat. 2023 Jan;144:108921. doi: 10.1016/j.jsat.2022.108921. Epub 2022 Oct 27.
10
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.医疗保险受益人的远程医疗服务的接受情况、阿片类药物使用障碍药物的获得和保留情况,以及在 COVID-19 大流行之前和期间的药物治疗过量情况。
JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284.

引用本文的文献

1
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults.青少年和青年阿片类药物使用障碍及过量用药的预防与管理
Curr Psychiatry Rep. 2025 Sep 12. doi: 10.1007/s11920-025-01638-0.
2
Clinician Willingness to Prescribe Medications for Opioid Use Disorder to Adolescents in Indiana.印第安纳州临床医生为青少年开阿片类药物使用障碍药物的意愿。
JAMA Netw Open. 2024 Sep 3;7(9):e2435416. doi: 10.1001/jamanetworkopen.2024.35416.
3
Narrative Review: Revised Principles and Practice Recommendations for Adolescent Substance Use Treatment and Policy.叙述性综述:青少年物质使用治疗与政策的修订原则及实践建议
J Am Acad Child Adolesc Psychiatry. 2025 Feb;64(2):123-142. doi: 10.1016/j.jaac.2024.03.010. Epub 2024 Mar 25.

本文引用的文献

1
Attitudes and beliefs among Georgia addiction treatment staff about medication for opioid use disorder in adolescents, young adults, and adults: a multi-mixed methods study.格鲁吉亚成瘾治疗人员对青少年、年轻成人和成人阿片类药物使用障碍药物治疗的态度和信念:一项多混合方法研究。
Am J Drug Alcohol Abuse. 2022 May 4;48(3):347-355. doi: 10.1080/00952990.2022.2043335. Epub 2022 Apr 13.
2
Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021.美国青少年药物过量死亡趋势,2010 年 1 月至 2021 年 6 月。
JAMA. 2022 Apr 12;327(14):1398-1400. doi: 10.1001/jama.2022.2847.
3
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.2019 年美国需要阿片类药物治疗的青少年和成年人中,阿片类药物使用障碍药物治疗的使用情况。
JAMA Netw Open. 2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821.
4
Preventing opioid use among justice-involved youth as they transition to adulthood: leveraging safe adults (LeSA).预防有犯罪记录的青少年在向成年期过渡期间使用阿片类药物:利用安全成年人(LeSA)。
BMC Public Health. 2021 Nov 20;21(1):2133. doi: 10.1186/s12889-021-12127-3.
5
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.青少年和青年中阿片类使用障碍治疗入院的趋势和与年龄相关的差异。
J Subst Abuse Treat. 2022 Jan;132:108584. doi: 10.1016/j.jsat.2021.108584. Epub 2021 Aug 8.
6
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.6 个医疗系统中参与初级保健的青少年获得阿片类药物使用障碍治疗药物的情况。
Addict Sci Clin Pract. 2021 Jul 7;16(1):46. doi: 10.1186/s13722-021-00249-3.
7
Sex differences in psychiatric comorbidity and clinical presentation in youths with conduct disorder.品行障碍青少年精神共病及临床表现的性别差异。
J Child Psychol Psychiatry. 2022 Feb;63(2):218-228. doi: 10.1111/jcpp.13428. Epub 2021 May 19.
8
Racial/Ethnic Disparities in Mutual Help Group Participation for Substance Use Problems.种族/民族差异在物质使用问题互助小组参与方面的体现。
Alcohol Res. 2021 Mar 11;41(1):03. doi: 10.35946/arcr.v41.1.03. eCollection 2021.
9
Medication for Adolescents and Young Adults With Opioid Use Disorder.青少年和青年阿片类药物使用障碍患者的药物治疗。
J Adolesc Health. 2021 Mar;68(3):632-636. doi: 10.1016/j.jadohealth.2020.12.129. Epub 2021 Jan 21.
10
Gender differences among adolescents with substance abuse problems at Maria clinics in Sweden.瑞典玛丽亚诊所存在药物滥用问题的青少年中的性别差异。
Nordisk Alkohol Nark. 2018 Feb;35(1):24-38. doi: 10.1177/1455072517751263. Epub 2018 Jan 19.